- Home
- WRAP vs ABOS Comparison
WRAP vs ABOS Comparison
Compare WRAP & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- ABOS
- Stock Information
- Founded
- WRAP 2016
- ABOS 1996
- Country
- WRAP United States
- ABOS United States
- Employees
- WRAP N/A
- ABOS N/A
- Industry
- WRAP Ordnance And Accessories
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- ABOS Health Care
- Exchange
- WRAP Nasdaq
- ABOS Nasdaq
- Market Cap
- WRAP 74.7M
- ABOS 66.6M
- IPO Year
- WRAP N/A
- ABOS 2021
- Fundamental
- Price
- WRAP $1.44
- ABOS $1.03
- Analyst Decision
- WRAP
- ABOS Strong Buy
- Analyst Count
- WRAP 0
- ABOS 3
- Target Price
- WRAP N/A
- ABOS $7.33
- AVG Volume (30 Days)
- WRAP 124.8K
- ABOS 201.3K
- Earning Date
- WRAP 05-15-2025
- ABOS 05-13-2025
- Dividend Yield
- WRAP N/A
- ABOS N/A
- EPS Growth
- WRAP N/A
- ABOS N/A
- EPS
- WRAP N/A
- ABOS N/A
- Revenue
- WRAP $3,796,000.00
- ABOS N/A
- Revenue This Year
- WRAP N/A
- ABOS N/A
- Revenue Next Year
- WRAP N/A
- ABOS N/A
- P/E Ratio
- WRAP N/A
- ABOS N/A
- Revenue Growth
- WRAP N/A
- ABOS N/A
- 52 Week Low
- WRAP $1.21
- ABOS $0.86
- 52 Week High
- WRAP $2.58
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- WRAP 44.91
- ABOS 48.71
- Support Level
- WRAP $1.30
- ABOS $0.99
- Resistance Level
- WRAP $1.50
- ABOS $1.06
- Average True Range (ATR)
- WRAP 0.09
- ABOS 0.06
- MACD
- WRAP 0.01
- ABOS 0.00
- Stochastic Oscillator
- WRAP 48.21
- ABOS 52.60
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.